Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ross River Virus Vaccine Lot Consistency Study
NCT01242670Phase 3Completed
- Sponsor
- Resilience Government Services
- Start
- Apr 2011
- Primary completion
- Oct 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of inactivated Ross River virus vaccine in Ross River virus infection (3 arms), sponsored by Resilience Government Services. Primary endpoints: Ross River Vaccine (RRV)-specific neutralizing titer, Rate of subjects with a RRV-specific neutralizing titer and 1 more. Started Apr 2011; status: completed.
02
Drugs
inactivated Ross River virus vaccine
03
Conditions
Ross River virus infection
Beyond the preview
Go deeper on NCT01242670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01242670.